Literature DB >> 23552096

Associations between prefrontal γ-aminobutyric acid concentration and the tryptophan hydroxylase isoform 2 gene, a panic disorder risk allele in women.

Nora Preuss1, Basira Salehi, Jan Willem van der Veen, Jun Shen, Wayne C Drevets, Colin Hodgkinson, David Goldman, Gregor Hasler.   

Abstract

Associations between the central serotonergic and γ-aminobutyric acid (GABA) systems play key roles in the prefrontal cortical regulation of emotion and cognition and in the pathophysiology and pharmacotherapy of highly prevalent psychiatric disorders. The goal of this study was to test the effects of common variants of the tryptophan hydroxylase isoform 2 (TPH2) gene on GABA concentration in the prefrontal cortex (PFC) using magnetic resonance spectroscopy. In this study involving 64 individuals, we examined the associations between prefrontal cortical GABA concentration and 12 single nucleotide polymorphisms (SNPs) spanning the TPH2 gene, including rs4570625 (-703 G/T SNP), a potentially functional TPH2 polymorphism that has been associated with decreased TPH2 mRNA expression and panic disorder. Our results revealed a significant association between increased GABA concentration in the PFC and the T-allele frequencies of two TPH2 SNPs, namely rs4570625 (-703 G/T) and rs2129575 (p⩽0.0004) and the C-allele frequency of one TPH2 SNP, namely rs1386491 (p = 0.0003) in female subjects. We concluded that rs4570625 (-703 G/T), rs2129575 and rs1386491 play a significant role in GABAergic neurotransmission and may contribute to the sex-specific dysfunction of the GABAergic system in the PFC.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23552096      PMCID: PMC4025920          DOI: 10.1017/S1461145713000254

Source DB:  PubMed          Journal:  Int J Neuropsychopharmacol        ISSN: 1461-1457            Impact factor:   5.176


  57 in total

1.  Inference of population structure using multilocus genotype data: linked loci and correlated allele frequencies.

Authors:  Daniel Falush; Matthew Stephens; Jonathan K Pritchard
Journal:  Genetics       Date:  2003-08       Impact factor: 4.562

2.  Analysis of the novel TPH2 gene in bipolar disorder and suicidality.

Authors:  V De Luca; D J Mueller; S Tharmalingam; N King; J L Kennedy
Journal:  Mol Psychiatry       Date:  2004-10       Impact factor: 15.992

3.  Extinction learning in humans: role of the amygdala and vmPFC.

Authors:  Elizabeth A Phelps; Mauricio R Delgado; Katherine I Nearing; Joseph E LeDoux
Journal:  Neuron       Date:  2004-09-16       Impact factor: 17.173

4.  Transmission disequilibrium of polymorphic variants in the tryptophan hydroxylase-2 gene in attention-deficit/hyperactivity disorder.

Authors:  S Walitza; T J Renner; A Dempfle; K Konrad; Ch Wewetzer; A Halbach; B Herpertz-Dahlmann; H Remschmidt; J Smidt; M Linder; L Flierl; U Knölker; S Friedel; H Schäfer; C Gross; J Hebebrand; A Warnke; K P Lesch
Journal:  Mol Psychiatry       Date:  2005-12       Impact factor: 15.992

5.  Addictions biology: haplotype-based analysis for 130 candidate genes on a single array.

Authors:  Colin A Hodgkinson; Qiaoping Yuan; Ke Xu; Pei-Hong Shen; Elizabeth Heinz; Elizabeth A Lobos; Elizabeth B Binder; Joe Cubells; Cindy L Ehlers; Joel Gelernter; John Mann; Brien Riley; Alec Roy; Boris Tabakoff; Richard D Todd; Zhifeng Zhou; David Goldman
Journal:  Alcohol Alcohol       Date:  2008-05-12       Impact factor: 2.826

6.  Sex differences in clinical presentation and response in panic disorder: pooled data from sertraline treatment studies.

Authors:  A H Clayton; R S Stewart; R Fayyad; C M Clary
Journal:  Arch Womens Ment Health       Date:  2005-11-15       Impact factor: 3.633

7.  Deficient serotonin neurotransmission and depression-like serotonin biomarker alterations in tryptophan hydroxylase 2 (Tph2) loss-of-function mice.

Authors:  J P R Jacobsen; W B Siesser; B D Sachs; S Peterson; M J Cools; V Setola; J H A Folgering; G Flik; M G Caron
Journal:  Mol Psychiatry       Date:  2011-05-03       Impact factor: 15.992

8.  Association study of tryptophan hydroxylase-2 gene in schizophrenia and its clinical features in Chinese Han population.

Authors:  Chen Zhang; Zezhi Li; Yang Shao; Bin Xie; Yasong Du; Yiru Fang; Shunying Yu
Journal:  J Mol Neurosci       Date:  2010-10-12       Impact factor: 3.444

9.  Increased cortical GABA concentrations in depressed patients receiving ECT.

Authors:  Gerard Sanacora; Graeme F Mason; Douglas L Rothman; Fahmeed Hyder; James J Ciarcia; Robert B Ostroff; Robert M Berman; John H Krystal
Journal:  Am J Psychiatry       Date:  2003-03       Impact factor: 18.112

10.  Serotonin as a modulator of glutamate- and GABA-mediated neurotransmission: implications in physiological functions and in pathology.

Authors:  L Ciranna
Journal:  Curr Neuropharmacol       Date:  2006-04       Impact factor: 7.363

View more
  4 in total

Review 1.  Sex differences modulating serotonergic polymorphisms implicated in the mechanistic pathways of risk for depression and related disorders.

Authors:  LeeAnn M Perry; Andrea N Goldstein-Piekarski; Leanne M Williams
Journal:  J Neurosci Res       Date:  2017-01-02       Impact factor: 4.164

2.  Functional characterization of the S41Y (C2755A) polymorphism of tryptophan hydroxylase 2.

Authors:  Nurgul Carkaci-Salli; Ugur Salli; Izel Tekin; Jeremy A Hengst; Moe K Zhao; T Lee Gilman; Anne M Andrews; Kent E Vrana
Journal:  J Neurochem       Date:  2014-06-28       Impact factor: 5.372

Review 3.  GABA System in Schizophrenia and Mood Disorders: A Mini Review on Third-Generation Imaging Studies.

Authors:  Chiara Chiapponi; Federica Piras; Fabrizio Piras; Carlo Caltagirone; Gianfranco Spalletta
Journal:  Front Psychiatry       Date:  2016-04-19       Impact factor: 4.157

4.  Genetically driven brain serotonin deficiency facilitates panic-like escape behavior in mice.

Authors:  J Waider; S Popp; M D Lange; R Kern; J F Kolter; J Kobler; N C Donner; K R Lowe; J H Malzbender; C J Brazell; M R Arnold; B Aboagye; A Schmitt-Böhrer; C A Lowry; H C Pape; K P Lesch
Journal:  Transl Psychiatry       Date:  2017-10-03       Impact factor: 6.222

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.